文献速递遗传性与小管间质肾病慢性肾脏病

定制化MUC1测序助力诊断常染色体显性肾小管间质性肾病及不明原因慢性肾脏病

Customized MUC1 Sequencing Enables Diagnosis of Autosomal Dominant Tubulointerstitial Kidney Disease and Unexplained CKD.
PubMed 文献 · Kidney Int Rep · 2026-09-25

本研究针对550例疑似遗传性肾病且缺乏明确遗传病因的患者,采用定制化短读长高通量测序(SR-HTS)及特异性生物信息学方法分析MUC1基因VNTR区域。结果28例(5%)诊断为ADTKD-MUC1,其中DupC占近90%,DupA占10%,超过半数需专门生物信息学分析才检出变异,并经Sanger、SNaPshot或长读长测序验证。该策略可提高诊断率并简化技术流程。

要点

  • 定制化SR-HTS可系统筛查MUC1基因VNTR区移码变异,诊断ADTKD-MUC1。
  • 在疑似遗传性肾病患者中ADTKD-MUC1检出率为5%(28/550)。
  • 超过半数病例需专门生物信息学分析才能识别MUC1变异。

核心结论

  • 定制化SR-HTS联合特异性生物信息学分析可用于系统筛查MUC1基因变异,提高ADTKD-MUC1诊断率并降低多方法序贯应用的技术复杂性。

研究设计与样本

  • 研究纳入550例疑似遗传性肾病且缺乏可识别遗传病因的患者,采用定制化短读长高通量测序(SR-HTS)及特异性生物信息学方法分析MUC1基因VNTR区域。

主要发现

  • 总体28例(5% [25/550])诊断为ADTKD-MUC1,其中DupC占近90%(25/28),DupA占10%。
  • 超过半数病例需要专门生物信息学分析才能检出变异。
  • 检出的变异根据位置和突变类型采用Sanger测序、SNaPshot或长读长测序(LRS)进行验证。

临床怎么用

  • 可将定制化SR-HTS整合至常规诊断流程,用于疑似遗传性肾病尤其是ADTKD-MUC1的筛查。
  • 对SR-HTS检出的MUC1 VNTR区变异,应根据位置和突变类型选择Sanger、SNaPshot或LRS验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Inherited kidney disease (IKD) is the second most common cause of prevalent kidney failure on kidney replacement therapy in Europe. However, it remains underdiagnosed, in part, because of suboptimal genetic test resolution. The genetic diagnosis of autosomal dominant tubulointerstitial kidney disease (ADTKD) caused by MUC1 gene variants (ADTKD-MUC1) is technically challenging. METHODS: We implemented a customized library for short-read high-throughput sequencing (SR-HTS) with specific bioinformatic approaches to enhance the genetic diagnosis of ADTKD-MUC1. Specific analysis of the variable number tandem repeat (VNTR)-MUC1 region was performed in 550 patients with suspected IKD lacking an identifiable genetic cause using customized SR-HTS. We used a combination of techniques to confirm the genetic variant detected by SR-HTS. RESULTS: Overall, 28 patients (5% [25/550]) had ADTKD-MUC1 with DupC (almost 90% [25/28] of MUC1 variants) or DupA (10%) MUC1 pathogenic frameshift variants. More than half of these cases required specialized bioinformatics analysis to detect the variants. These variants were validated using Sanger, SNaPshot, or long-read sequencing (LRS) according to the location and mutation type. CONCLUSION: This study presents an applicable solution of a customized SR-HTS approach for the systematic screening of MUC1 gene variants, with particular emphasis on the detection of frameshift alterations within the VNTR region that generate pathogenic MUC1 neoproteins associated with ADTKD-MUC1. Integrating this strategy into routine diagnostic workflows increased the overall diagnostic yield while reducing the technical complexity associated with the sequential application of multiple methodologies.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. García-Aznar JM, Besada-Cerecedo ML, Aguirre NL, et al. Customized MUC1 Sequencing Enables Diagnosis of Autosomal Dominant Tubulointerstitial Kidney Disease and Unexplained CKD. Kidney Int Rep. 2026. PMID: 42964607. doi:10.1016/j.ekir.2026.107095

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。